We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cilia Defect Found in Rare Genetic Disorder

By Biotechdaily staff writers
Posted on 08 Oct 2003
Researchers have found that a mutation in the BBS8 gene causes a defective protein to be produced in the cilia of cells in the brain, lung, eyes, and kidneys of patients suffering from the rare genetic disorder Bardet-Biedl syndrome (BBS). More...
BBS is a genetically heterogeneous disorder characterized primarily by retinal dystrophy, obesity, renal malformations, and learning disabilities.

The BBS8 gene was identified by performing gene scans on members of families with members suffering from BBS. In these individuals, defective BBS8 protein was found in ciliated structures, such as the connecting cilium of the retina and columnar epithelial cells in the lung. In cells, BBS8 localized to centrosomes and basal bodies and interacted with PCM1, a protein probably involved in ciliogenesis. Experiments by investigators at Johns Hopkins University (Baltimore, MD, USA; www.jhu.edu) working with the C elegans worm model revealed that the defective protein was expressed exclusively in ciliated neurons, and contained regulatory elements for RFX, a transcription factor that modulates the expression of genes associated with ciliogenesis and intraflagellar transport. These findings were published in the September 21, 2003, online edition of Nature.

"BBS is a relatively rare genetic disorder, but it has traits common to many people,” said senior author Dr. Nicholas Katsanis, assistant professor in the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University. "We do not know yet how the ciliary defect might lead to obesity or learning disabilities, but the finding provides a new avenue to studying these genetically murky traits.”




Related Links:
Johns Hopkins University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.